An unexpected case of rapid progression of lymphomatous lesions in a man recently diagnosed with angioimmunoblastic T-cell lymphoma (AITL) after receiving a BNT162b2 mRNA vaccine booster. The study suggests the need to explore the possible impact of mRNA vaccines on neoplasms affecting T follicular helper cells, which are strongly activated by these vaccines.
AITL is a rare type of non-Hodgkin lymphoma that affects the immune system, and the BNT162b2 mRNA vaccine is a widely used COVID-19 vaccine. The study highlights the importance of monitoring the potential adverse effects of mRNA vaccines, especially in patients with pre-existing conditions, and further investigating their impact on T cell
– 6 months after BNT mRNA vaccination, the whole body lymphatic system became cancerous, and the cancer was stage 4.
– In 728 recipients, there was no change in COVID antibody levels between dose 1 and dose 2, but nearly 1/5 of the lymph nodes in dose 2 were enlarged, suggesting that the vaccine was not only ineffective but also harmful.
– The subject of the article (the patient) is the co-author of the paper, who also mentioned the problem of hypermetabolism of lymph nodes in 31 health workers. It is a first-hand information
lymphomas.
It is important to note that this is a single case report and further research is needed to understand the potential link between mRNA vaccines and lymphoma progression. Nonetheless, the study underscores the importance of ongoing surveillance and monitoring of vaccine safety, especially as new vaccines are developed and administered to millions of people worldwide.
Leave a Reply